Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Lynparza Maintenance Therapy Improves Survival in Relapsed, BRCA-Positive Ovarian Cancer

May 14th 2020

Treatment with Lynparza in the maintenance setting extended overall survival by more than a year in women with platinum-sensitive relapsed ovarian cancer with BRCA1/2 mutations.

FDA Approves Combination of Lynparza and Avastin as Maintenance Treatment for Advanced Ovarian Cancer

May 8th 2020

Lynparza and Avastin are now approved for patients with advanced ovarian cancer that carries a specific mutation and has responded to previous treatment with platinum-based chemotherapy plus Avastin.

Ovarian Cancer

May 6th 2020

Understanding ovarian cancer.

FDA Approves Zejula For Maintenance Treatment in Advanced Epithelial Ovarian Cancer

April 29th 2020

The Food and Drug Administration has approved the use of Zejula as a frontline maintenance treatment for adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer who responded to chemotherapy.

A Patient with Ovarian Cancer Weathers the COVID-19 Storm at Her Local Health Center

April 16th 2020

The COVID-19 pandemic has changed how people receive health care services. For Donna Wiegle, director of the Mill Pond Health Center in Maine, and cervical cancer survivor and patient with ovarian cancer, the pandemic hasn’t yet changed how her island’s health center provides residents with routine care.

Living with Peace of Mind As a Two-Time Cancer Survivor

April 14th 2020

A two-time survivor shares how taking action led her doctors to catch an aggressive second cancer.

Phase 3 Trial Fails to Improve Progression-Free Survival in Previously Untreated Epithelial Ovarian Cancer

April 13th 2020

After failing to meet its primary endpoint of progression-free survival, the JAVELIN Ovarian PARP 100 clinical trial was stopped.

Refine and Retry, Getting Ovarian Cancer Treatment Right for Patients

April 10th 2020

CURE®’s Editor-in-Chief weighs in on how the treatment and detection landscape needs to be refined to help patients with ovarian cancer.

Genetic Testing: Are Over-the-Counter Options Reliable?

April 9th 2020

An expert raises her concerns about direct-to-consumer testing and shares ways people can protect themselves.

Breastfeeding Lowers the Risk of Ovarian Cancer

April 8th 2020

Regardless of breastfeeding duration, women who did so after giving birth had a lower risk of developing ovarian cancer, including high-grade tumors.

Managing Ovarian Cancer Recurrence

April 6th 2020

Women with ovarian cancer are living longer than ever, even those whose disease returns after initial treatment.

Survey Reveals Women Will Bear Side Effects, if a Drug Might Lengthen Life

April 4th 2020

PARP inhibitors show promise in lengthening the life of women with breast cancer, and they're willing to bear the side effects of the treatment.

How PARP Inhibitors Work In Women

April 2nd 2020

These targeted therapies fight disease by stopping the fix-it process in damaged cancer cells.

Understanding Risks for Breast Implant-Associated Lymphoma

February 20th 2020

Genetic Mutations in Men

February 20th 2020

Laws and Legislation Protecting Those with a Genetic Predisposition

February 20th 2020

Talking About Direct-To-Consumer Genetic Testing

February 20th 2020

PARP Inhibitors Will Likely Expand Treatment Options for Those Who Have Ovarian Cancer

February 18th 2020

PARP Inhibitors are opening new doors in cancer treatment by targeting vulnerabilities in cancer that researchers are beginning to understand better.

An Expanding Role For PARP Inhibitors Shows Promise In Treating Ovarian Cancer

February 14th 2020

PARP inhibitors interfere with cancer’s ability to repair damage to its DNA. They are becoming increasingly useful in treating ovarian cancer.

Unique Genetic Change Found in Rare Ovarian Tumor Could Spare Patients from Unnecessary Treatment

February 5th 2020

Investigators are studying a rare ovarian tumor called sclerosing stromal tumor, a benign tumor that can be misdiagnosed as cancer.

CURE's Top Stories: January 2020

February 2nd 2020

Take a look back at the top five CURE® stories for January 2020.

Friday Frontline: Cancer Updates, Research and Education on January 31, 2020

January 31st 2020

From NFL Hall of Famer Kurt Warner leading a recognition service for cancer caregivers during the Super Bowl to Tylenol’s key ingredient possibly being added to California’s proposition 65 list for chemicals that may cause cancer, here’s what is making headlines in the cancer space this week.

A Tale of Two Misdiagnoses

January 23rd 2020

In this week’s episode, a pair who is forever connected by their genetic risk for cancer talked about the revelations that came from a study they participated in that changed both of their lives.

Finding Success In Immunotherapy Trials

January 20th 2020

One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.

Appreciating The Gift of Time is the Best New Year Resolution For This Cancer Patient

January 15th 2020

Patients with cancer are acutely aware of how time is finite, and that's ok. They can appreciate the fit of time all the better.

Findings Show No Statistically Significant Link Between Talcum Powder And Ovarian Cancer

January 9th 2020

In a new study, researchers set out to prove whether or not there was a statistically significant risk of ovarian cancer from the use of talc-based powder.

When I Needed to Talk

January 8th 2020

One cancer survivor discusses the need to talk to others during and after her treatment, and the healing ability of listening as well.

The Space In Between

January 8th 2020

One woman reflects on the fact that no one is immortal.

What Happens After Genetic Testing? A Podcast Illuminates a Challenging Road

January 8th 2020

Launched in April 2018, the podcast hosted by Eleanor Griffith of Grey Genetics tells the stories of people living with genetic mutations that predispose them to cancer or other diseases.

The Falling, Wandering and Crashing Business of Cancer Treatment Side Effects

December 26th 2019

If you’ve experienced neuropathy, you know what it entails.